BioMed Realty owns and operates high quality life science real estate comprising 16.6 million square feet concentrated in leading innovation markets throughout the United States and the United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder and Cambridge, U.K. BioMed maintains a premier development platform with 2.9 million square feet of Class A properties in construction and 8.5 million square feet of future development in these core markets to meet the growing demand of the life science and technology industries.